ABSCI CORP (ABSI) Current Ratio
- Current ratio · latest quarter: Value 10.63×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 10.63× | Current assets / current liabilities. $208.27M ÷ $19.60M ≈ 10.63× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 208.27M USD | Assets, Current |
| Current obligations | 19.60M USD | Liabilities, Current |
| Cash and equivalents | 107.86M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 93.28M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 7.16M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $208.27M | $19.60M | $107.86M | $93.28M | (m) | (m) | $7.16M | (m) | 10.63× |
| 2026-03-31 | $131.97M | $20.03M | $8.63M | $117.08M | (m) | (m) | $8.82M | (m) | 6.59× |
| 2025-12-31 | $149.57M | $22.77M | $20.02M | $124.27M | (m) | (m) | $2.76M | (m) | 6.57× |
| 2025-09-30 | $174.99M | $29.71M | $9.48M | $143.00M | $1.00M | (m) | $4.59M | (m) | 5.89× |
| 2025-06-30 | $137.40M | $31.32M | $38.02M | (m) | $700.00K | (m) | $8.21M | (m) | 4.39× |
| 2025-03-31 | $155.98M | $27.28M | $46.99M | (m) | $1.38M | (m) | $4.95M | (m) | 5.72× |
| 2024-12-31 | $133.83M | $28.66M | $41.21M | $71.21M | (m) | (m) | $2.95M | (m) | 4.67× |
| 2024-09-30 | $150.14M | $26.69M | $38.20M | (m) | (m) | (m) | $1.67M | (m) | 5.63× |
| 2024-06-30 | $165.19M | $25.47M | $42.94M | (m) | (m) | (m) | $1.69M | (m) | 6.49× |
| 2024-03-31 | $181.80M | $25.29M | $58.83M | (m) | (m) | (m) | $1.65M | (m) | 7.19× |
| 2023-12-31 | $120.58M | $29.56M | $72.36M | (m) | $2.19M | (m) | $1.50M | (m) | 4.08× |
| 2023-09-30 | $134.71M | $27.97M | $69.73M | (m) | (m) | (m) | $1.91M | (m) | 4.82× |
| 2023-06-30 | $148.04M | $25.48M | $61.05M | (m) | (m) | (m) | $1.85M | (m) | 5.81× |
| 2023-03-31 | $165.32M | $27.20M | $11.41M | (m) | (m) | (m) | $1.93M | (m) | 6.08× |
| 2022-12-31 | $186.86M | $30.27M | $59.95M | (m) | (m) | (m) | $2.41M | (m) | 6.17× |
| 2022-09-30 | $201.38M | $30.03M | $107.32M | $73.99M | (m) | (m) | $1.86M | (m) | 6.71× |
| 2022-06-30 | $227.89M | $31.69M | $206.02M | (m) | (m) | (m) | $5.47M | (m) | 7.19× |
| 2022-03-31 | $255.96M | $41.88M | $226.00M | (m) | (m) | (m) | $6.74M | (m) | 6.11× |
| 2021-12-31 | $273.08M | $33.86M | $252.57M | (m) | (m) | (m) | $8.38M | (m) | 8.07× |
| 2021-09-30 | $300.67M | $30.25M | $279.26M | (m) | (m) | (m) | $6.37M | (m) | 9.94× |
| 2021-06-30 | $112.39M | $29.76M | $99.45M | (m) | (m) | (m) | $9.00M | (m) | 3.78× |
| 2020-12-31 | $73.23M | $10.10M | $69.87M | (m) | (m) | (m) | $2.12M | (m) | 7.25× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |